The Center for International Blood and Marrow Transplant Research (CIBMTR) is a clinical research program dedicated to addressing important issues in the field of hematopoietic cell transplantation (HCT). CIBMTR maintains a large outcomes registry with information for more than 330,000 HCT recipients in over 300 centers and provides statistical support for analyzing those data. A separately funded Research Repository of donor-recipient specimens linked to these clinical data is available for a large subset of patients. Use of this Resource by hundreds of investigators around the world during the current and previous funding cycles have contributed to >700 publications on important issues and to improved global collaboration in data exchange and HCT research. With continuation of U24-CA76518, CIBMTR will continue to build on the infrastructure made possible by this support to facilitate in-depth exploration of clinical, immunogenetic, quality of life, and health services issues related to HCT. This application proposes to enhance this Resource and to advance its utility through the following Specific Aims: Resource Development: Provide the biomedical community a high-quality clinical database and state-of-the-art statistical support to address important issues in HCT and related fields through continued enhancement of data collection and management technology and procedures, expansion of the Resource to include patient-reported outcomes, gathering and disseminating data necessary for health services research and data on some non-HCT patients, development and application of novel statistical techniques, and collaboration with national and international networks in HCT and related fields. Resource Utilization: Increase use of data and statistical resources maintained by the CIBMTR to support studies with important clinical and policy implications, and enhance Working and Advisory Committee and Statistical Center processes to prioritize and complete these studies.

Public Health Relevance

The CIBMTR continues to play a unique and important role in facilitating clinical research in HCT. It is committed to developing its research database and statistical capabilities to meet the needs of investigators in a rapidly evolving field. It will buld on the infrastructure made possible by support from U24-CA76518 and its partnerships to better serve the research and medical community and address important issues in HCT.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-17
Application #
8661712
Study Section
Special Emphasis Panel (ZCA1-SRLB-V (J1))
Program Officer
Merritt, William D
Project Start
1998-03-01
Project End
2018-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
17
Fiscal Year
2014
Total Cost
$3,193,930
Indirect Cost
$524,148
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Stiff, Patrick J; Montesinos, Pau; Peled, Tony et al. (2018) Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. Biol Blood Marrow Transplant 24:1463-1470
Hill, Brian T; Ahn, Kwang Woo; Hu, Zhen-Huan et al. (2018) Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. Biol Blood Marrow Transplant 24:581-586
Pulsipher, Michael A; Logan, Brent R; Chitphakdithai, Pintip et al. (2018) Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant :
Ahn, Kwang Woo; Kim, Soyoung (2018) Variable selection with group structure in competing risks quantile regression. Stat Med 37:1577-1586
Myers, Regina M; Hill, Brian T; Shaw, Bronwen E et al. (2018) Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer 124:816-825
Drobyski, William R; Szabo, Aniko; Zhu, Fenlu et al. (2018) Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. Haematologica 103:717-727
Sullivan, Keith M; Majhail, Navneet S; Bredeson, Christopher et al. (2018) Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 24:1961-1964
Stroncek, David F; Shaw, Bronwen E; Logan, Brent R et al. (2018) Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. Biol Blood Marrow Transplant 24:175-184
Kumar, Anita J; Kim, Soyoung; Hemmer, Michael T et al. (2018) Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood Adv 2:1022-1031
Alousi, Amin; Wang, Tao; Hemmer, Michael T et al. (2018) Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival. Biol Blood Marrow Transplant :

Showing the most recent 10 out of 641 publications